Luminex's EBIT per Share for the
three
months ended in Mar. 2021 was $0.28.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2021 was $1.15.
During the past 3 years, the average EBIT per Share Growth Rate was 1.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Luminex's EBIT per Share or its related term are showing as below:
LMNX'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -25.6 Med: 17.8 Max: 90.1
Current: 1.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Luminex was 90.10% per year. The lowest was -25.60% per year. And the median was 17.80% per year.
LMNX's 3-Year EBIT Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 5.9
vs LMNX: 1.60
Luminex's EBIT for the
three
months ended in Mar. 2021 was $13.2 Mil.
Luminex EBIT per Share Historical Data
The historical data trend for Luminex's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Luminex (NAS:LMNX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Luminex EBIT per Share Related Terms
Thank you for viewing the detailed overview of Luminex's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Luminex Corp develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. It primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex's market segments mainly include Infectious disease, Personalized medicine, and Human genetics. It offers various solutions in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. The vast majority of the company's revenue is earned in the United States. The products offered are xMAP Products, ARIES Products and VERIGENE Products, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LMNX has been successfully added to your 